Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > converting data

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Aug 31, 2021 4:53am

286 Views

Post# 33786585

RE:RE:RE:RE:RE:RE:converting data

Yes Pandora the data should have beeen presented clearly leaving the reader - not the Company - to be the judge of whether it could then be meaningfully analysed.

The design of this Trial made sure that it would never showcase the full potential of TLD-1433 and have held since for Rutherrin. Is this as it should be at last in GLP? Again, not a clue.

Another triumph of a Quarterly and really worth the long wait?

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec